Pomalidomide is a pharmaceutical raw material that is a derivative of thalidomide, modified by the addition of an amino group. It is primarily supplied for use in the manufacturing of antineoplastic agents and has been investigated as an angiogenesis inhibitor and immunomodulator.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Pomalidomide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Thalidomide
pharmaceutical raw material
Altretamine
pharmaceutical raw material
Ixabepilone
pharmaceutical raw material
Betulinic acid
pharmaceutical raw material
Dromostanolone propionate
pharmaceutical raw material
(RS)-lenalidomide
pharmaceutical raw material
6,7-dimethoxy-2-N,2-N-dimethylquinazoline-2,4-diamine
pharmaceutical raw material
Prazosin
pharmaceutical raw material
The international HS code for Pomalidomide (CAS 19171-19-8) is 2925.19.
2925.19
2925 19 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
UVSMNLNDYGZFPF-UHFFFAOYSA-N
C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
Sourcing Pomalidomide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.